Aurobindo Pharma’s stock shows resistance at Rs 1177, with a promising technical outlook. Traders are advised to consider a Bull Call Spread strategy proposed by Mehta for potential upside movements.
Uday Kotak lauds MUFG stake buy in Shriram Finance but flags big question on next move
Uday Kotak welcomed MUFG Bank’s Rs 39,618 crore investment in Shriram Finance, questioning whether it should remain an NBFC or eventually seek a banking licence